PTEN, a tumor suppressor gene that negatively regulates activation of the PI3K/Akt/mTOR pathway, is deficient in over 50 percent of urothelial carcinomas due to loss of heterozygosity (LOH). The gene discussed is PTEN; the disease is urothelial carcinoma.